Working to overcome drug shortages

In 2018, US hospitals faced a critical shortage of injectable pain management medicines after a competitor experienced significant manufacturing disruption.

The shortage resulted in rationing of the medicines, which had a substantial impact on hospitals and at times resulted in surgeries being delayed.

In response, we significantly increased production of these products at our injectables facility in the US, adding production lines, recruiting additional staff and manufacturing around the clock. We also worked closely with the FDA and US Drug Enforcement Agency to ensure we had an adequate supply of raw materials.